ATE399019T1 - Verwendungen von tgap7 zur modulation der aktivierung von leukozyten - Google Patents
Verwendungen von tgap7 zur modulation der aktivierung von leukozytenInfo
- Publication number
- ATE399019T1 ATE399019T1 AT01938157T AT01938157T ATE399019T1 AT E399019 T1 ATE399019 T1 AT E399019T1 AT 01938157 T AT01938157 T AT 01938157T AT 01938157 T AT01938157 T AT 01938157T AT E399019 T1 ATE399019 T1 AT E399019T1
- Authority
- AT
- Austria
- Prior art keywords
- pharmaceutical compositions
- tgap7
- protein
- furthermore
- treatment
- Prior art date
Links
- 230000004913 activation Effects 0.000 title 1
- 210000000265 leukocyte Anatomy 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 5
- 102000040430 polynucleotide Human genes 0.000 abstract 4
- 108091033319 polynucleotide Proteins 0.000 abstract 4
- 239000002157 polynucleotide Substances 0.000 abstract 4
- 102000004169 proteins and genes Human genes 0.000 abstract 4
- 108090000623 proteins and genes Proteins 0.000 abstract 4
- 239000013598 vector Substances 0.000 abstract 2
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- 208000035473 Communicable disease Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 208000026935 allergic disease Diseases 0.000 abstract 1
- 230000000172 allergic effect Effects 0.000 abstract 1
- 230000000692 anti-sense effect Effects 0.000 abstract 1
- 230000001363 autoimmune Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 210000000056 organ Anatomy 0.000 abstract 1
- 238000002054 transplantation Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Marine Sciences & Fisheries (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00109462 | 2000-05-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE399019T1 true ATE399019T1 (de) | 2008-07-15 |
Family
ID=8168619
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01938157T ATE399019T1 (de) | 2000-05-03 | 2001-05-03 | Verwendungen von tgap7 zur modulation der aktivierung von leukozyten |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20030166599A1 (de) |
| EP (1) | EP1278535B1 (de) |
| AT (1) | ATE399019T1 (de) |
| AU (1) | AU2001263888A1 (de) |
| DE (1) | DE60134545D1 (de) |
| WO (1) | WO2001082948A2 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1346040A2 (de) * | 2000-09-11 | 2003-09-24 | Nuvelo, Inc. | Nukleinsäuren und polypeptide |
| EP2308892A1 (de) | 2009-10-01 | 2011-04-13 | Sanofi-Aventis | Verwendung von siRNA gegen Sipa1l1 zur Reduzierung von Lipogenese |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0996726B1 (de) * | 1997-08-29 | 2003-12-10 | Brigham And Women's Hospital | T-zell-membranprotein (tirc7), davon abgeleitete peptide und antikörper und ihre verwendungen |
| US6440696B1 (en) * | 1999-07-28 | 2002-08-27 | New England Medical Center | E6 targeted protein (E6TP1) |
-
2001
- 2001-05-03 US US10/275,140 patent/US20030166599A1/en not_active Abandoned
- 2001-05-03 AT AT01938157T patent/ATE399019T1/de not_active IP Right Cessation
- 2001-05-03 EP EP01938157A patent/EP1278535B1/de not_active Expired - Lifetime
- 2001-05-03 DE DE60134545T patent/DE60134545D1/de not_active Expired - Lifetime
- 2001-05-03 AU AU2001263888A patent/AU2001263888A1/en not_active Abandoned
- 2001-05-03 WO PCT/EP2001/005010 patent/WO2001082948A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001082948A2 (en) | 2001-11-08 |
| WO2001082948A3 (en) | 2002-05-23 |
| AU2001263888A1 (en) | 2001-11-12 |
| US20030166599A1 (en) | 2003-09-04 |
| DE60134545D1 (de) | 2008-08-07 |
| EP1278535A2 (de) | 2003-01-29 |
| EP1278535B1 (de) | 2008-06-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE485371T1 (de) | Varianten des menschlichen koagulationsfaktors vii | |
| ATE443161T1 (de) | Mittel und verfahren für den nachweis von methylierter dna | |
| NO20013701D0 (no) | HER-2/neu-fusjonsproteiner | |
| ATE444967T1 (de) | Spezifische bindungsmittel von human angiopoietin-2 | |
| HUP0500345A2 (hu) | Készítmények és alkalmazások tüdőrák kezelésére és diagnosztizálására | |
| PT1587532E (pt) | Péptidos derivados de survivina e a sua utilização | |
| ATE500323T1 (de) | Subtilisin-variante | |
| PT1090033E (pt) | Particulas de proteinas de envelope do hcv: utilizacao para vacinacao | |
| DK43890D0 (da) | Nucleinsyre, vektorer og celler indeholdende den, derudfra fremstillede produkter og disses anvendelse | |
| WO2001068708A3 (en) | Human and humanized fap-alpha-specific antibodies | |
| ATE430161T1 (de) | Peptid aus hsp70 welches nk zellaktivtät stimuliert und seine verwendung | |
| AR042968A1 (es) | Anticuerpos de virus anti-dengue composiciones metodos y usos | |
| ATE232399T1 (de) | Verfahren zur modulierung des wachstums kollateraler arterien und / oder anderer arterien aus bestehenden arteriolen verbindungen | |
| DE69841322D1 (de) | Hepatitis c rezeptorprotein cd81 | |
| ATE384263T1 (de) | Verfahren zur bestimmung von biologischen agenzien in lebenden zielzellen | |
| ATE399019T1 (de) | Verwendungen von tgap7 zur modulation der aktivierung von leukozyten | |
| DE60122721D1 (de) | Diagnostische verwendungen des t-zell proteins tzon7, der davon abgeleiteten peptide und des antikörpers | |
| WO2004011496A3 (en) | Novel t-cell proteins, peptides and antibodies derived therefrom and uses thereof | |
| WO2001032614A3 (en) | Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof | |
| ATE414776T1 (de) | Fusionsproteine zur spezifisichen behandlung von krebs und autoimmunkrankheiten | |
| DE60113535D1 (de) | Kompositionen und verwendungen von cgi-69 | |
| DE60141740D1 (de) | Tumor- und seneszenzsmarker | |
| TW200635951A (en) | Specific binding agents of human angiopoietin-2 | |
| CY1109617T1 (el) | Ενα πεπτιδιο hsp70 που διεγειρει τη δραστηριοτητα φυσικων φονικων κυτταρων (νκ) και χρησεις αυτου |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |